JPRN-jRCT1031220275
Recruiting
未知
A prospective observational study on the efficacy and safety of the Gefapixant in patients with interstitial lung disease
Abe Mitsuhiro0 sites30 target enrollmentAugust 17, 2022
Conditionsinterstitial lung disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- interstitial lung disease
- Sponsor
- Abe Mitsuhiro
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with interstitial lung disease
- •Patients who have been fully informed of the study and given the consent
- •More than 18 years old patients
Exclusion Criteria
- •Patients unable to give the consent
- •Patients allergic to sulfonamide group
- •Other patients deemed unsuitable for the study by the principal investigator or the sub\-investigator
- •Patients already taking gefapixant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A prospective observational study on the efficacy of switching to sertraline in depressive patients who failed treatment with duloxetinemajor depressive disorderJPRN-UMIN000009609Tokyo Womens Medical University100
Not yet recruiting
Not Applicable
Study of effectiveness and side effects of light therapy with oral medication called Khellin in Vitiligo patients.CTRI/2020/02/023495Dr Lavin Bhatia
Completed
Not Applicable
A group study for outcomes to see if freezing nerves with local anaesthetics can be used for collarbone surgeries.Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissueCTRI/2021/05/033826KPC Medical College Hospital30
Unknown
Not Applicable
A prospective observational study of the efficacy and safety of CPT-11 based regimens (CPT-11+platinum analogues) for UGT1A1 genotype guided patientsSmall cell lung cancer, non-small cell lung cancer, cervical cancer, ovarian cancer and gastric cancer (inoperable or recurrent)JPRN-jRCT1080220914DAIICHI SANKYO COMPANY, LIMITED1,000
Unknown
Not Applicable
A prospective observational study of the efficacy and safety of CPT-11 based regimens for UGT1A1 genotype guided patients with metastatic colorectal cancerMetastatic colorectal cancer (adenocarcinoma)JPRN-jRCT1080220913DAIICHI SANKYO COMPANY, LIMITED2,000